Token Allocation (Macro Distribution)
A. Allocation Overview
Public Sale
35%
350,000,000
10% unlocked at TGE; 15% quarterly vesting over 18 months
Team & Advisors
15%
150,000,000
24-month cliff; linear vesting over 48 months
Reserve Fund
20%
200,000,000
Locked; milestone-based release for R&D and AI integration
Liquidity & Market Makers
10%
100,000,000
Gradual release post-listing to maintain price stability
Marketing & Partnerships
10%
100,000,000
12-month linear vesting linked to verified deliverables
Community & Staking Incentives
10%
100,000,000
Distributed gradually over 5 years for staking, governance, and referrals
Smart Contract Controlled Locks
All token vesting schedules for team members, advisors, early investors, and strategic partners are managed through blockchain-based smart contracts. These smart contracts automatically enforce time-based release conditions, ensuring that no entity can manually alter, accelerate, or bypass the vesting process. This eliminates human interference and promotes absolute trust among investors.
For example, tokens allocated to the Team & Advisors are locked for 24 months (cliff period) and then released gradually over 48 months according to predefined intervals. The Reserve Fund, Marketing, and Partnership tokens are similarly governed by automated smart contracts that release tokens based on milestone achievements or pre-set vesting terms.
By leveraging immutable blockchain protocols, Medimint guarantees transparency and compliance, allowing anyone to verify vesting progress via blockchain explorers. This system ensures all token releases occur in a predictable, auditable, and fair manner.
Phase-wise Unlocking
To protect the MDMT token’s price stability post-listing, a phase-wise unlocking mechanism is implemented for pre-sale and early-stage investors. Only a small portion of tokens (10%) is unlocked at the Token Generation Event (TGE), while the remaining tokens are vested and released gradually — typically 15% per quarter over the next 18 months.
This structured unlocking schedule discourages early dumping, which often leads to sudden price crashes after token listings. Instead, it promotes steady market liquidity and ensures that investors remain aligned with the long-term success of the ecosystem.
Through phase-wise unlocking, Medimint maintains a healthy balance between circulating supply and market demand. As new utility milestones — such as staking activation, hospital integration, and data monetization — are achieved, the token’s real-world value supports its gradual release.
Together, Smart Contract Controlled Locks and Phase-wise Unlocking form the backbone of Medimint’s responsible tokenomics, ensuring transparency, price resilience, and sustainable growth in both investor confidence and market performance.
B. Strategic Purpose of Each Allocation
Public Sale
Raise liquidity and enable widespread investor participation; supports platform deployment and listing.
Team & Advisors
Incentivize long-term commitment from the founding team and advisors driving Medimint’s expansion.
Reserve Fund
Maintain capital for technological scaling, AI integration, and strategic mergers or acquisitions.
Liquidity & Market Makers
Ensure deep exchange liquidity and counter volatility post-listing.
Marketing & Partnerships
Finance brand expansion, influencer campaigns, and strategic healthcare collaborations.
Community & Staking Incentives
Strengthen user engagement through staking, referral rewards, and DAO participation.
Last updated